MB100

N/A

Report date: 2023/05/23 14:03:59

Base Information

Drug NameMB100
Drug Alias NameMB100MB-100
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionC-X-C motif chemokine receptor 4 antagonists
TargetsC-X-C motif chemokine receptor 4
Therapy Area/IndicationsLiver CirrhosisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMainline Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesMainline Biosciences Inc
Inactive CompaniesN/A
Active IndicationsLiver CirrhosisNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A